14.07.2023 • NewsWuxiWuXi BiologicsWuXi STA

Wuxi Biologics Plans Spin-off and Separate Listing of Wuxi XDC

Chinese contract research, development, and manufacturing organization (CRDMO) Wuxi Biologics announced the planned spin-off and separate listing of its subsidiary WuXi XDC on the Hong Kong Stock Exchange. Upon completion of the proposed listing, Wuxi XDC will remain a consolidated subsidiary.

A joint venture between WuXi Biologics and Wuxi STA, Wuxi XDC provides CRDMO services for bioconjugates, including antibody drug conjugates (ADCs).

Chris Chen, CEO of Wuxi Biologics and Chairman of Wuxi XDC, commented: “The establishment and development of Wuxi XDC is another testament to Wuxi Biologics’ effective business growth strategy, and demonstrates the company’s vision and determination to further strengthen its leadership in the bioconjugate industry.”

According to Wuxi, the ADC and bioconjugate market are at a growth inflection point, offering Wuxi XDC opportunities in the fast-growing global bioconjugate market.

Moreover, the proposed spin-off is expected to give Wuxi XDC an independent fundraising platform in the broad capital market to meet the capital needs for building a global leading ADC and bioconjugate service provider and realize the growth potential of the ADC and bioconjugate market.

Wuxi XDC has brought multiple ADC projects to the Investigational New Drug (IND) filing stage in 15 months or less, nearly cutting in half the traditional development timeline, the company said. As of May 2023, 102 on-going integrated projects are under development at WuXi XDC, including 44 post-IND bioconjugate projects, among which 14 projects are in Phase 2/3.

© Shutterstock/ustas7777777
© Shutterstock/ustas7777777

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.